Bioactive Compounds in Traditional Chinese Medicine

Traditional Chinese Medicine (TCM) harnesses a diverse array of bioactive compounds derived from plants, minerals and animal products to treat a spectrum of diseases. Phytochemicals such as flavonoids, terpenoids, alkaloids and coumarins form the cornerstone of this pharmacopeia. Key examples include artemisinin from Artemisia annua, berberine from Coptis chinensis and tanshinones from Salvia miltiorrhiza, each of which exhibits potent antimalarial, antimicrobial, cardioprotective and anticancer activities. These compounds often act on multiple molecular targets, modulating signalling pathways, enzyme activities and gene expression networks. Advances in extraction technologies, including supercritical fluid and green solvent methods, have enhanced yield and purity while reducing environmental impact. In parallel, nanocarrier systems have been developed to improve solubility, stability and targeted delivery, thereby overcoming barriers of poor bioavailability. Modern analytical platforms such as high-resolution mass spectrometry, NMR spectroscopy and omics approaches have enabled comprehensive characterisation of complex extracts, facilitating quality control and identification of novel constituents. Integration of systems biology with synthetic biology and structural biology has further elucidated mechanisms of action, paving the way for rational design of derivatives with improved efficacy and safety. Collectively, this interdisciplinary endeavour has elevated bioactive TCM compounds from traditional remedies to candidates for mainstream therapeutic development, underscoring their global significance and translational potential.

Research from Nature Portfolio

Recent studies have unveiled the structural basis of anticancer activity for tanshinone IIA, demonstrating its binding to pyruvate kinase M2, which suppresses glycolytic flux in tumour cells and reprogrammes metabolic pathways. Parallel work employing integrated metabolomics and transcriptomics has revealed that berberine modulates microRNA expression to ameliorate insulin resistance and lipid dysregulation in metabolic syndrome models. Additionally, biophysical analyses have characterised the interaction of baicalein with viral proteases, highlighting its potential as a broad-spectrum antiviral agent through allosteric inhibition of enzymatic active sites. These insights offer a molecular framework for optimisation and drug design of established TCM compounds.

Bioactive Compounds in Traditional Chinese Medicine publication trend

The graph below shows the total number of articles in bioactive compounds in traditional chinese medicine across all publications each year (not limited to Nature Index journals).

Technical terms

Endoperoxide bridge: A chemical structure containing two adjacent oxygen atoms in a cyclic peroxide, crucial for antimalarial activity of artemisinin.

Glycolytic flux: The rate at which glucose molecules are processed through the glycolysis pathway in cellular metabolism.

Metabolomics: The large-scale study of small molecules and metabolic intermediates within biological systems.

Transcriptomics: The analysis of complete sets of RNA transcripts produced by the genome under specific conditions.

Hepatotoxicity: The capacity of a substance to cause damage to the liver.

Nanocarrier: A nanoscale vehicle designed to deliver drugs or bioactive compounds to specific cells or tissues.

References

1. Comprehensive review of the skin use of bakuchiol: physicochemical properties, sources, bioactivities, nanotechnology delivery systems, regulatory and toxicological concerns. Phytochemistry Reviews (2024).
2. Psoraleae Fructus Ethanol Extract Induced Hepatotoxicity via Impaired Lipid Metabolism Caused by Disruption of Fatty Acid β‐Oxidation. Oxidative Medicine and Cellular Longevity (2023).
3. Psoralea corylifolia L.: a comprehensive review of its botany, traditional uses, phytochemistry, pharmacology, toxicology, quality control and pharmacokinetics. Chinese Medicine (2023).